{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:25:53Z","timestamp":1789475153493,"version":"build-2803163510"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.semcancer.2025.12.006","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:13:59Z","timestamp":1765844039000},"page":"74-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Obesity and GEP-NEN: what\u2019s new?"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9383-0913","authenticated-orcid":false,"given":"M.","family":"Boschetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Hasballa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Patelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Piras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Albertelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3390\/ijms24021418","article-title":"The complex histopathological and immunohistochemical spectrum of neuroendocrine tumors-an overview of the latest classifications","volume":"24","author":"Gheorghi\u0219an-G\u0103l\u0103\u021beanu","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr. Oncol. Rep."},{"issue":"10","key":"10.1016\/j.semcancer.2025.12.006_bib4","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.3390\/biomedicines10102660","article-title":"Inflammation related to obesity in the etiopathogenesis of gastroenteropancreatic neuroendocrine neoplasms","volume":"10","author":"Budek","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40618-022-01905-4","article-title":"Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies [published correction appears in J Endocrinol Invest. 2023 Jan;46(1):203. doi: 10.1007\/s40618-022-01924-1.]","volume":"46","author":"Ruggeri","year":"2023","journal-title":"J. Endocrinol. Invest"},{"issue":"7","key":"10.1016\/j.semcancer.2025.12.006_bib6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11154-021-09647-z","article-title":"\"Present and future of immunotherapy in Neuroendocrine Tumors\"","volume":"22","author":"Albertelli","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.semcancer.2025.12.006_bib8","unstructured":"WHO: Obesity and overweight. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight\u3009."},{"key":"10.1016\/j.semcancer.2025.12.006_bib9","unstructured":"WHO European Regional Obesity Report 2022. \u3008https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289057738\u3009."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib10","first-page":"1","article-title":"Sovrappeso e obesit\u00e0 nella popolazione adulta in Italia: trend temporali, differenze socio-anagrafiche e regionali con focus sulla Regione Campania (2023)","volume":"4","author":"Masocco","year":"2023","journal-title":"Boll. Epidemiol. Naz."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10198-021-01358-1","article-title":"The economic burden of obesity in Italy: a cost-of-illness study","volume":"23","author":"d'Errico","year":"2022","journal-title":"Eur. J. Health Econ."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s13679-024-00580-1","article-title":"Strengths and Limitations of BMI in the diagnosis of obesity: what is the path forward? [published correction appears in Curr Obes Rep. 2024 Dec;13(4):831. doi: 10.1007\/s13679-024-00584-x.]","volume":"13","author":"Sweatt","year":"2024","journal-title":"Curr. Obes. Rep."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40519-016-0279-3","article-title":"SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO)","volume":"21","author":"Santini","year":"2016","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.semcancer.2025.12.006_bib14","unstructured":"Linea Guida ISS su Terapia del sovrappeso e dell'obesit\u00e0 resistenti al trattamento comportamentale nella popolazione adulta con comorbilit\u00e0 metaboliche. \u3008https:\/\/associazionemediciendocrinologi.it\/index.php\/position-statement\/position-statement-2022\/4698-linee-guida-terapia-del-sovrappeso-e-dell-obesita-resistenti-al-trattamento-comportamentale-nella-popolazione-adulta-con-comorbilita-metaboliche\u3009."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11154-020-09579-0","article-title":"The role of the Mediterranean diet on weight loss and obesity-related diseases","volume":"21","author":"Estruch","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2010.09.073","article-title":"The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals","volume":"57","author":"Kastorini","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine Society clinical practice guideline [published correction appears in J Clin Endocrinol Metab. 2015 May;100(5):2135-6. doi: 10.1210\/jc.2015-1782.]","volume":"100","author":"Apovian","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N. Engl. J. Med"},{"issue":"10401","key":"10.1016\/j.semcancer.2025.12.006_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(23)01053-X","article-title":"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA","volume":"402","author":"Rosenstock","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2025.12.006_bib20","first-page":"S12","article-title":"Mode of action of orlistat","volume":"21 3","author":"Guerciolini","year":"1997","journal-title":"Int J. Obes. Relat. Metab. Disord."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/clpt.1994.104","article-title":"Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers","volume":"56","author":"Zhi","year":"1994","journal-title":"Clin. Pharm. Ther."},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/j.1552-4604.1995.tb04034.x","article-title":"Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers","volume":"35","author":"Zhi","year":"1995","journal-title":"J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/oby.2008.461","article-title":"Rational design of a combination medication for the treatment of obesity","volume":"17","author":"Greenway","year":"2009","journal-title":"Obes. (Silver Spring)"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40519-023-01537-4","article-title":"SICOB-endorsed national Delphi consensus on obesity treatment optimization: focus on diagnosis, pre-operative management, and weight regain\/insufficient weight loss approach","volume":"28","author":"Zappa","year":"2023","journal-title":"Eat. Weight Disord."},{"issue":"7121","key":"10.1016\/j.semcancer.2025.12.006_bib25","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib26","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","article-title":"Obesity and cardiovascular disease","volume":"118","author":"Ortega","year":"2016","journal-title":"Circ. Res"},{"issue":"3 1","key":"10.1016\/j.semcancer.2025.12.006_bib27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2007.01.002","article-title":"Multiple risk factors for cardiovascular disease and diabetes mellitus","volume":"120","author":"Smith","year":"2007","journal-title":"Am. J. Med"},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.orcp.2016.07.003","article-title":"The interface of depression and obesity","volume":"11","author":"Jantaratnotai","year":"2017","journal-title":"Obes. Res Clin. Pr."},{"issue":"7","key":"10.1016\/j.semcancer.2025.12.006_bib30","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"issue":"9945","key":"10.1016\/j.semcancer.2025.12.006_bib31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 [published correction appears in Lancet. 2014 Aug 30;384(9945):746]","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.semcancer.2025.12.006_bib32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1017\/S002966510800712X","article-title":"The second World Cancer Research Fund\/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective","volume":"67","author":"Wiseman","year":"2008","journal-title":"Proc. Nutr. Soc."},{"issue":"7043","key":"10.1016\/j.semcancer.2025.12.006_bib34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/435752a","article-title":"Cancer: inflammation by remote control","volume":"435","author":"Mantovani","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J. Clin. Invest"},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib36","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J. Lipid Res"},{"issue":"20","key":"10.1016\/j.semcancer.2025.12.006_bib37","doi-asserted-by":"crossref","first-page":"16683","DOI":"10.1074\/jbc.M011695200","article-title":"Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4","volume":"276","author":"Lee","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1189\/jlb.68.4.437","article-title":"Leptin in the regulation of immunity, inflammation, and hematopoiesis","volume":"68","author":"Fantuzzi","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbadis.2013.05.017","article-title":"Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochim Biophys. Acta"},{"issue":"8","key":"10.1016\/j.semcancer.2025.12.006_bib40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib41","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/en.2009-0070","article-title":"Minireview: Obesity and breast cancer: the estrogen connection","volume":"150","author":"Cleary","year":"2009","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/0008-5472.CAN-09-2257","article-title":"Obesity and breast cancer: progress to understanding the relationship","volume":"70","author":"Brown","year":"2010","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.semcancer.2025.12.006_bib43","first-page":"871","article-title":"Obesity and cancer: the risks, science, and potential management strategies","volume":"19","author":"McTiernan","year":"2005","journal-title":"Oncol. (Williston Park"},{"issue":"38","key":"10.1016\/j.semcancer.2025.12.006_bib44","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1038\/sj.onc.1207899","article-title":"Prevention of cancers of the breast, endometrium and ovary","volume":"23","author":"Pike","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2025.12.006_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fendo.2015.00077","article-title":"The Role of the Insulin\/IGF System in Cancer: Lessons Learned from Clinical Trials and the Energy Balance-Cancer Link","volume":"6","author":"Bowers","year":"2015","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2009.26.4473","article-title":"Associations of insulin resistance and adiponectin with mortality in women with breast cancer","volume":"29","author":"Duggan","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10549-009-0603-y","article-title":"Metabolic profile, physical activity, and mortality in breast cancer patients","volume":"121","author":"Emaus","year":"2010","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1200\/JCO.2002.20.1.42","article-title":"Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study","volume":"20","author":"Goodwin","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JCO.2010.28.4752","article-title":"Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study","volume":"29","author":"Irwin","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ijc.21812","article-title":"Metabolic syndrome as a prognostic factor for breast cancer recurrences","volume":"119","author":"Pasanisi","year":"2006","journal-title":"Int J. Cancer"},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jnutbio.2005.06.011","article-title":"Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes","volume":"17","author":"Gunter","year":"2006","journal-title":"J. Nutr. Biochem"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jnci\/djn415","article-title":"Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women","volume":"101","author":"Gunter","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/1055-9965.EPI-06-0693","article-title":"Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women","volume":"16","author":"Eliassen","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1200\/JCO.2008.17.9945","article-title":"Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer","volume":"27","author":"Wolpin","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib55","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/1573399815666190906130544","article-title":"Fasting Insulin and Risk of Cancer Related Mortality in Non-diabetic Adults: A Dose-response Meta-analysis of Cohort Studies","volume":"16","author":"Ghanavati","year":"2020","journal-title":"Curr. Diabetes Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.diabet.2017.03.006","article-title":"Association of fasting serum insulin and cancer mortality in a healthy population - 28-year follow-up of the French TELECOM Study","volume":"44","author":"Wargny","year":"2018","journal-title":"Diabetes Metab."},{"issue":"8","key":"10.1016\/j.semcancer.2025.12.006_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","article-title":"Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment","volume":"5","author":"Sulli","year":"2019","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41574-018-0122-1","article-title":"Circadian clocks and insulin resistance","volume":"15","author":"Stenvers","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib60","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","article-title":"Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis","volume":"123","author":"Protani","year":"2010","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib61","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3520","article-title":"Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis","volume":"4","author":"Petrelli","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib62","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1158\/1078-0432.CCR-09-2636","article-title":"Obesity is an independent prognostic variable in colon cancer survivors","volume":"16","author":"Sinicrope","year":"2010","journal-title":"Clin. Cancer Res"},{"issue":"18","key":"10.1016\/j.semcancer.2025.12.006_bib63","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1200\/JCO.19.02185","article-title":"Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer","volume":"38","author":"Troeschel","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.semcancer.2025.12.006_bib64","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/pros.24054","article-title":"Abdominal and pelvic adipose tissue distribution and risk of prostate cancer recurrence after radiation therapy","volume":"80","author":"Di Bella","year":"2020","journal-title":"Prostate"},{"issue":"30","key":"10.1016\/j.semcancer.2025.12.006_bib65","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2012.41.8574","article-title":"Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review","volume":"30","author":"Paskett","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib66","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/21681805.2013.803151","article-title":"Role of abdominal obesity for functional outcomes and complications in men treated with radical prostatectomy for prostate cancer: results of the Multicenter Italian Report on Radical Prostatectomy (MIRROR) study","volume":"48","author":"Gacci","year":"2014","journal-title":"Scand. J. Urol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40519-018-0489-y","article-title":"The obesity paradox in cancer: clinical insights and perspectives","volume":"23","author":"Trestini","year":"2018","journal-title":"Eat. Weight Disord."},{"issue":"9","key":"10.1016\/j.semcancer.2025.12.006_bib68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","article-title":"The Obesity Paradox in Cancer: a Review","volume":"18","author":"Lennon","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.semcancer.2025.12.006_bib69","doi-asserted-by":"crossref","DOI":"10.4158\/EP14203.OR","article-title":"Decreased Inpatient Mortality in Obese Patients with Abdominal Nets","author":"Glazer","year":"2014","journal-title":"Endocr. Pr."},{"issue":"9","key":"10.1016\/j.semcancer.2025.12.006_bib70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/cancers10090293","article-title":"Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors","volume":"10","author":"Santos","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.semcancer.2025.12.006_bib71","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.3390\/jcm11206026","article-title":"Visceral Obesity Is Associated with Shorter Progression-Free Survival in Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Neoplasia","volume":"11","author":"Santos","year":"2022","journal-title":"J. Clin. Med"},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib72","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/metabo12111150","article-title":"Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms","volume":"12","author":"Lan","year":"2022","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib73","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11695-008-9541-8","article-title":"Carcinoid tumors and morbid obesity","volume":"19","author":"Mottin","year":"2009","journal-title":"Obes. Surg."},{"key":"10.1016\/j.semcancer.2025.12.006_bib74","article-title":"Gastric carcinoid and obesity: association or coincidence? Report of two cases and literature review","volume":"2013","author":"Al-Harbi","year":"2013","journal-title":"Case Rep. Gastrointest. Med"},{"key":"10.1016\/j.semcancer.2025.12.006_bib75","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amsu.2018.09.010","article-title":"Which is the correlation between carcinoid tumor and Laparoscopic Sleeve Gastrectomy? A case series and literature review","volume":"36","author":"Sista","year":"2018","journal-title":"Ann. Med Surg. (Lond. )"},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib76","article-title":"Obesity: A Chronic Low-Grade Inflammation and Its Markers","volume":"14","author":"Khanna","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.semcancer.2025.12.006_bib77","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/ATVBAHA.119.312467","article-title":"B Lymphocytes and Adipose Tissue Inflammation","volume":"40","author":"Srikakulapu","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2025.12.006_bib78","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3389\/fimmu.2019.01587","article-title":"Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib79","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0004563216629997","article-title":"Cytokine profiles in overweight and obese subjects and normal weight individuals matched for age and gender","volume":"53","author":"Azizian","year":"2016","journal-title":"Ann. Clin. Biochem"},{"issue":"10","key":"10.1016\/j.semcancer.2025.12.006_bib80","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.3390\/curroncol31100456","article-title":"Searching for New Biomarkers of Neuroendocrine Tumors: A Comparative Analysis of Chromogranin A and Inflammatory Cytokines in Patients with Neuroendocrine Tumors","volume":"31","author":"Budek","year":"2024","journal-title":"Curr. Oncol."},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.annonc.2022.02.226","article-title":"Inflammatory bowel disease and risk of adenocarcinoma and neuroendocrine tumors in the small bowel","volume":"33","author":"Yu","year":"2022","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2025.12.006_bib82","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1002\/cam4.2327","article-title":"Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.semcancer.2025.12.006_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.672499","article-title":"Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?","volume":"12","author":"Giannetta","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"20","key":"10.1016\/j.semcancer.2025.12.006_bib84","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.3390\/jcm11206191","article-title":"Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors","volume":"11","author":"Geisler","year":"2022","journal-title":"J. Clin. Med"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib85","first-page":"445","article-title":"Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms","volume":"20","author":"Herman Mahe\u010di\u0107","year":"2020","journal-title":"Bosn. J. Basic Med Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000362339","article-title":"New insights into the role of chronic inflammation and cytokines in the etiopathogenesis of gastroenteropancreatic neuroendocrine tumors","volume":"99","author":"Cigrovski Berkovic","year":"2014","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib87","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.yexmp.2007.08.018","article-title":"IL-6\u2013174\u2009C\/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs)","volume":"83","author":"Berkovi\u0107","year":"2007","journal-title":"Exp. Mol. Pathol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib88","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/dna.2011.1317","article-title":"Interleukin 1\u03b2 gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors","volume":"31","author":"Cigrovski Berkovi\u0107","year":"2012","journal-title":"DNA Cell Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib89","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000445045","article-title":"Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group Study","volume":"61","author":"Salman","year":"2016","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib90","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10147-017-1111-4","article-title":"Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors","volume":"22","author":"Arima","year":"2017","journal-title":"Int J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12957-017-1169-5","article-title":"Predictive value of preoperative peripheral blood neutrophil\/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study","volume":"15","author":"Tong","year":"2017","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2025.12.006_bib92","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.12659\/MSM.907182","article-title":"Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors","volume":"23","author":"Zhou","year":"2017","journal-title":"Med Sci. Monit."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib93","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/EC-19-0541","article-title":"Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms","volume":"9","author":"Zhou","year":"2020","journal-title":"Endocr. Connect"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib94","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3892\/ol.2017.5716","article-title":"Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors","volume":"13","author":"Luo","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib95","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1245\/s10434-017-6241-4","article-title":"Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis","volume":"25","author":"Gaitanidis","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib96","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00384-019-03356-5","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery","volume":"34","author":"Pozza","year":"2019","journal-title":"Int J. Colorectal Dis."},{"issue":"8","key":"10.1016\/j.semcancer.2025.12.006_bib97","article-title":"The Correlation of the Neutrophil-Lymphocyte Ratio and the Platelet-Lymphocyte Ratio With Pathological Findings in Neuroendocrine Tumors","volume":"13","author":"Kulahci","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.semcancer.2025.12.006_bib98","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231186041","article-title":"HORMONET: a phase II trial of tamoxifen for estrogen\/progesterone receptor-positive neuroendocrine tumors","volume":"15","author":"Barros","year":"2023","journal-title":"Ther. Adv. Med Oncol."},{"key":"10.1016\/j.semcancer.2025.12.006_bib99","first-page":"B10","article-title":"Inhibition of Estrogen Receptor Alpha Radiosensitizes Neuroendocrine Tumors","volume":"89","author":"L. Schwarz","year":"2022","journal-title":"Endocr. Abstr."},{"issue":"18","key":"10.1016\/j.semcancer.2025.12.006_bib100","doi-asserted-by":"crossref","first-page":"9820","DOI":"10.3390\/ijms25189820","article-title":"Adipokines in Neuroendocrine Tumors: An Evaluation of the Serum Levels of Ghrelin and Leptin","volume":"25","author":"Strzelczyk","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.semcancer.2025.12.006_bib101","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.3390\/cancers15133517","article-title":"Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms","volume":"15","author":"Bocian-Jastrz\u0119bska","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib102","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4093\/dmj.2020.0250","article-title":"Hyperinsulinemia in Obesity, Inflammation, and Cancer [published correction appears in Diabetes Metab J. 2021 Jul;45(4):622. doi: 10.4093\/dmj.2021.0131.]","volume":"45","author":"Zhang","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.semcancer.2025.12.006_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.615082","article-title":"Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms","volume":"11","author":"Zhuge","year":"2020","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"22","key":"10.1016\/j.semcancer.2025.12.006_bib104","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.3390\/cancers13225735","article-title":"Diabetes and Cancer: Risk, Challenges, Management and Outcomes","volume":"13","author":"Shahid","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2025.12.006_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2018.04.013","article-title":"Diabetes and pancreatic neuroendocrine tumours: Which interplays, if any?","volume":"67","author":"Gallo","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib106","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1017\/S0029665112000092","article-title":"Obesity, inflammation and the immune system","volume":"71","author":"de Heredia","year":"2012","journal-title":"Proc. Nutr. Soc."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib107","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00018-023-05098-8","article-title":"Targeting the NF-\u03baB pathway as a potential regulator of immune checkpoints in cancer immunotherapy","volume":"81","author":"Ebrahimi","year":"2024","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib108","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12964-023-01398-5","article-title":"Interplay of oxidative stress, cellular communication and signaling pathways in cancer","volume":"22","author":"Iqbal","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib109","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cpt.2023.09.002","article-title":"Relationship between visceral obesity and prognosis in patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy","volume":"2","author":"Ji","year":"2023","journal-title":"Cancer Pathog. Ther."},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib110","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/metabo12111150","article-title":"Exploring the Relationship between Obesity, Metabolic Syndrome and Neuroendocrine Neoplasms","volume":"12","author":"Lan","year":"2022","journal-title":"Metabolites"},{"issue":"9","key":"10.1016\/j.semcancer.2025.12.006_bib111","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s40618-022-01805-7","article-title":"Impact of baseline body mass index on the outcomes of patients with neuroendocrine neoplasms","volume":"45","author":"Abdel-Rahman","year":"2022","journal-title":"J. Endocrinol. Invest"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjc.6603526","article-title":"Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours","volume":"96","author":"Marrache","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"39","key":"10.1016\/j.semcancer.2025.12.006_bib113","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1093\/eurheartj\/ehad504","article-title":"The fiction of the obesity paradox","volume":"44","author":"Guglin","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib114","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/1055-9965.EPI-16-0439","article-title":"The Obesity Paradox in Cancer-Moving Beyond BMI","volume":"26","author":"Strulov Shachar","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12902-024-01625-1","article-title":"The association between visceral fat obesity and prefrailty in Chinese older adults: a cross-sectional study","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.semcancer.2025.12.006_bib116","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.canlet.2021.09.021","article-title":"Help or hindrance: The obesity paradox in cancer treatment response","volume":"522","author":"O\u2032Connell","year":"2021","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.semcancer.2025.12.006_bib117","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/cancers12051230","article-title":"The Effects of Obesity on Anti-Cancer Immunity and Cancer Immunotherapy","volume":"12","author":"Woodall","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib118","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40618-024-02462-8","article-title":"Nutritional aspects in neuroendocrine neoplasms. bridging the gap between dietary interventions and cancer care strategies: a scoping review","volume":"48","author":"Massironi","year":"2025","journal-title":"J. Endocrinol. Invest"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib119","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrad026","article-title":"Effect of obesity on perioperative outcomes following gastrointestinal surgery: meta-analysis","volume":"7","author":"Cullinane","year":"2023","journal-title":"BJS Open"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ags3.12049","article-title":"Obesity as a surgical risk factor","volume":"2","author":"Ri","year":"2017","journal-title":"Ann. Gastroenterol. Surg."},{"key":"10.1016\/j.semcancer.2025.12.006_bib121","article-title":"Sarcopenic obesity and therapeutic outcomes in gastrointestinal surgical oncology: A meta-analysis","volume":"9","author":"Wang","year":"2022","journal-title":"Front Nutr."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100153","volume":"6","author":"Silvestris","year":"2021","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib123","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/CEJ.0000000000000900","article-title":"Association between priori and posteriori dietary patterns and gastric cancer risk: an updated systematic review and meta-analysis of observational studies","volume":"34","author":"Luo","year":"2025","journal-title":"Eur. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib124","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/CEJ.0000000000000861","article-title":"Mediterranean diet and colorectal adenomas: a systematic review and meta-analysis of observational studies","volume":"33","author":"Jafari Nasab","year":"2024","journal-title":"Eur. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.semcancer.2025.12.006_bib126","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3390\/nu10121854","article-title":"Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness","volume":"10","author":"Barrea","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib127","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/00365521.2018.1430848","article-title":"Nutritional status and nutritional risk in patients with neuroendocrine tumors","volume":"53","author":"Borre","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000442983","article-title":"Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia","volume":"104","author":"Maasberg","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"7","key":"10.1016\/j.semcancer.2025.12.006_bib129","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1080\/10408398.2017.1390729","article-title":"The management of neuroendocrine tumours: A nutritional viewpoint","volume":"59","author":"Gallo","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"9","key":"10.1016\/j.semcancer.2025.12.006_bib130","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/jgh.16638","article-title":"Gastrointestinal side effects of somatostatin analogs in neuroendocrine tumors: a focused review","volume":"39","author":"Marasco","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib131","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/jn\/nxz268","article-title":"The World Cancer Research Fund\/American Institute for Cancer Research Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions","volume":"150","author":"Clinton","year":"2020","journal-title":"J. Nutr."},{"issue":"2 3","key":"10.1016\/j.semcancer.2025.12.006_bib132","first-page":"E36","article-title":"Modern vision of the Mediterranean diet","volume":"63","author":"Kiani","year":"2022","journal-title":"J. Prev. Med Hyg."},{"issue":"7","key":"10.1016\/j.semcancer.2025.12.006_bib133","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/bcp.13589","article-title":"Oleuropein, a component of extra virgin olive oil, lowers postprandial glycaemia in healthy subjects","volume":"84","author":"Carnevale","year":"2018","journal-title":"Br. J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib134","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.numecd.2014.09.001","article-title":"Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort. The PREDIMED randomized trial","volume":"25","author":"Medina-Rem\u00f3n","year":"2015","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib135","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3233\/JAD-231100","article-title":"The Effects of Pomegranate Seed Oil on Mild Cognitive Impairment","volume":"97","author":"Chatzikostopoulos","year":"2024","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.semcancer.2025.12.006_bib136","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/1750-3841.14198","article-title":"Antitumor Perspectives of Oleuropein and Its Metabolite Hydroxytyrosol: Recent Updates","volume":"83","author":"Imran","year":"2018","journal-title":"J. Food Sci."},{"key":"10.1016\/j.semcancer.2025.12.006_bib137","article-title":"Ketogenic diet in clinical populations-a narrative review","volume":"11","author":"Zemer","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.semcancer.2025.12.006_bib138","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4103\/njcp.njcp_509_18","article-title":"Survival outcomes of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer","volume":"23","author":"Iyikesici","year":"2020","journal-title":"Niger. J. Clin. Pr."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib139","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/01635581.2019.1645864","article-title":"A Ketogenic Diet Is Acceptable in Women with Ovarian and Endometrial Cancer and Has No Adverse Effects on Blood Lipids: A Randomized, Controlled Trial","volume":"72","author":"Cohen","year":"2020","journal-title":"Nutr. Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib140","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3892\/ijo.2014.2382","article-title":"ERGO: a pilot study of ketogenic diet in recurrent glioblastoma [published correction appears in Int J Oncol. 2014 Dec;45(6):2605]","volume":"44","author":"Rieger","year":"2014","journal-title":"Int J. Oncol."},{"issue":"18","key":"10.1016\/j.semcancer.2025.12.006_bib141","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.3390\/cancers14184402","article-title":"Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches","volume":"14","author":"Muscogiuri","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib142","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/10408398.2020.1832955","article-title":"Ketogenic diet: a tool for the management of neuroendocrine neoplasms?","volume":"62","author":"Muscogiuri","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib143","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/nu16040477","article-title":"Calorie Restriction and Time-Restricted Feeding: Effective Interventions in Overweight or Obese Patients Undergoing Radiotherapy Treatment with Curative Intent for Cancer","volume":"16","author":"Vega","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib144","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00394-021-02666-1","article-title":"Short-term fasting in glioma patients: analysis of diet diaries and metabolic parameters of the ERGO2 trial","volume":"61","author":"Voss","year":"2022","journal-title":"Eur. J. Nutr."},{"issue":"23","key":"10.1016\/j.semcancer.2025.12.006_bib145","doi-asserted-by":"crossref","first-page":"13068","DOI":"10.3390\/ijms222313068","article-title":"Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area","volume":"22","author":"Tulipano","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2025.12.006_bib146","article-title":"Preventive and Therapeutic effects of Metformin in Cancer: A Meta-Analysis of RCT and Cohort Studies","author":"Getu MA","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib147","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/j.gastro.2018.04.010","article-title":"Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and\/or Somatostatin Analogues","volume":"155","author":"Pusceddu","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib148","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib149","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"7","key":"10.1016\/j.semcancer.2025.12.006_bib150","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db12-1686","article-title":"Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors","volume":"62","author":"Butler","year":"2013","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib151","first-page":"206","article-title":"Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials","volume":"48","author":"Nreu","year":"2023","journal-title":"Minerva Endocrinol. (Torino)"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib152","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/EDE.0000000000001196","article-title":"Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with Diabetes","volume":"31","author":"Santella","year":"2020","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib153","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12902-024-01775-2","article-title":"Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis","volume":"24","author":"Shabil","year":"2024","journal-title":"BMC Endocr. Disord."},{"issue":"8","key":"10.1016\/j.semcancer.2025.12.006_bib154","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.3390\/ijms25084346","article-title":"Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review","volume":"25","author":"Feier","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib155","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2337\/dc22-1148","article-title":"GLP-1 Receptor Agonists and the Risk of Thyroid Cancer","volume":"46","author":"Bezin","year":"2023","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib156","doi-asserted-by":"crossref","DOI":"10.1530\/EC-23-0257","article-title":"Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?","volume":"12","author":"Lisco","year":"2023","journal-title":"Endocr. Connect"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib157","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bcp.14210","article-title":"Naltrexone-bupropion (Mysimba) in management of obesity: A systematic review and meta-analysis of unpublished clinical study reports [published correction appears in Br J Clin Pharmacol. 2024 Jun;90(6):1531-1533. doi: 10.1111\/bcp.16065.]","volume":"86","author":"Onakpoya","year":"2020","journal-title":"Br. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib158","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3390\/cancers16061240","article-title":"Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy","volume":"16","author":"Ciwun","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.semcancer.2025.12.006_bib159","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1007\/s11695-023-06909-4","article-title":"Bariatric Surgery for Patients with Overweight\/Obesity. A Comprehensive Grading Methodology and Network Metanalysis of Randomized Controlled Trials on Weight Loss Outcomes and Adverse Events","volume":"33","author":"De Luca","year":"2023","journal-title":"Obes. Surg."},{"issue":"3","key":"10.1016\/j.semcancer.2025.12.006_bib160","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00464-025-11528-4","article-title":"Bariatric surgery and relevant comorbidities: a systematic review and meta-analysis","volume":"39","author":"Wunker","year":"2025","journal-title":"Surg. Endosc."},{"issue":"9","key":"10.1016\/j.semcancer.2025.12.006_bib161","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s11695-018-3230-z","article-title":"High-Percentage Pathological Findings in Obese Patients Suggest that Esophago-gastro-duodenoscopy Should Be Made Mandatory Prior to Bariatric Surgery","volume":"28","author":"D'Silva","year":"2018","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib162","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11695-010-0112-4","article-title":"High incidence of appendix carcinoid tumors among candidates for bariatric surgery: diagnostic and therapeutic implications","volume":"21","author":"Crea","year":"2011","journal-title":"Obes. Surg."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib163","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jamadermatol.2019.3240","article-title":"Association of Bariatric Surgery With Skin Cancer Incidence in Adults With Obesity: A Nonrandomized Controlled Trial","volume":"156","author":"Taube","year":"2020","journal-title":"JAMA Dermatol."},{"issue":"10","key":"10.1016\/j.semcancer.2025.12.006_bib164","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1016\/S2666-7568(23)00141-1","article-title":"Long-term incidence of haematological cancer after bariatric surgery or usual care in the Swedish Obese Subjects study: a prospective cohort study","volume":"4","author":"Sj\u00f6holm","year":"2023","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.semcancer.2025.12.006_bib165","first-page":"151","article-title":"Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management","volume":"8","author":"Beavis","year":"2016","journal-title":"Int J. Women\u2019s. Health"},{"issue":"12","key":"10.1016\/j.semcancer.2025.12.006_bib166","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00464-013-3127-9","article-title":"Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis","volume":"27","author":"Tee","year":"2013","journal-title":"Surg. Endosc."},{"issue":"9","key":"10.1016\/j.semcancer.2025.12.006_bib167","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.tips.2018.07.003","article-title":"Training the Circadian Clock, Clocking the Drugs, and Drugging the Clock to Prevent, Manage, and Treat Chronic Diseases","volume":"39","author":"Sulli","year":"2018","journal-title":"Trends Pharm. Sci."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib168","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/endrev\/bnab027","article-title":"Time-restricted Eating for the Prevention and Management of Metabolic Diseases","volume":"43","author":"Manoogian","year":"2022","journal-title":"Endocr. Rev."},{"issue":"6416","key":"10.1016\/j.semcancer.2025.12.006_bib169","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aau2095","article-title":"A time to fast","volume":"362","author":"Di Francesco","year":"2018","journal-title":"Science"},{"issue":"47","key":"10.1016\/j.semcancer.2025.12.006_bib170","doi-asserted-by":"crossref","first-page":"16647","DOI":"10.1073\/pnas.1413965111","article-title":"Meal frequency and timing in health and disease","volume":"111","author":"Mattson","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib171","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41467-020-20743-7","article-title":"Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models","volume":"12","author":"Das","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib172","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.21873\/anticanres.13280","article-title":"Time-restricted Feeding Attenuates High-fat Diet-enhanced Spontaneous Metastasis of Lewis Lung Carcinoma in Mice","volume":"39","author":"Yan","year":"2019","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib173","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.18632\/aging.102021","article-title":"Time-restricted feeding delays the emergence of the age-associated, neoplastic-prone tissue landscape","volume":"11","author":"Serra","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.semcancer.2025.12.006_bib174","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.21037\/tcr.2018.10.18","article-title":"Gut flora shift caused by time-restricted feeding might protect the host from metabolic syndrome, inflammatory bowel disease and colorectal cancer","volume":"7","author":"Hu","year":"2018","journal-title":"Transl. Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2025.12.006_bib175","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.21873\/anticanres.14555","article-title":"Therapeutic Time-restricted Feeding Reduces Renal Tumor Bioluminescence in Mice but Fails to Improve Anti-CTLA-4 Efficacy","volume":"40","author":"Turbitt","year":"2020","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib176","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/pcan.2010.24","article-title":"Effect of intermittent fasting on prostate cancer tumor growth in a mouse model","volume":"13","author":"Thomas","year":"2010","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib177","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13058-017-0821-x","article-title":"Nighttime eating and breast cancer among Chinese women in Hong Kong","volume":"19","author":"Li","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"8","key":"10.1016\/j.semcancer.2025.12.006_bib178","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamaoncol.2016.0164","article-title":"Prolonged Nightly Fasting and Breast Cancer Prognosis","volume":"2","author":"Marinac","year":"2016","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.semcancer.2025.12.006_bib179","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cmet.2018.04.010","article-title":"Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes","volume":"27","author":"Sutton","year":"2018","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib180","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/ajcn\/nqaa192","article-title":"Two weeks of early time-restricted feeding (eTRF) improves skeletal muscle insulin and anabolic sensitivity in healthy men","volume":"112","author":"Jones","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib181","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/jc.2011-2454","article-title":"Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors","volume":"97","author":"Waser","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib182","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000371804","article-title":"Does somatostatin or gastric inhibitory peptide receptor expression correlate with tumor grade and stage in gut neuroendocrine tumors?","volume":"101","author":"K\u00f6rner","year":"2015","journal-title":"Neuroendocrinology"},{"issue":"9","key":"10.1016\/j.semcancer.2025.12.006_bib183","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/s41366-021-00865-8","article-title":"Obesity-related gut hormones and cancer: novel insight into the pathophysiology","volume":"45","author":"Guzzardi","year":"2021","journal-title":"Int J. Obes. (Lond. )"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib184","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41367-020-0017-1","article-title":"From obesity through gut microbiota to cardiovascular diseases: a dangerous journey","volume":"10","author":"Marzullo","year":"2020","journal-title":"Int J. Obes. Suppl."},{"key":"10.1016\/j.semcancer.2025.12.006_bib185","article-title":"Evolving concepts: how diet and the intestinal microbiome act as modulators of breast malignancy","volume":"2013","author":"Shapira","year":"2013","journal-title":"ISRN Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2025.12.006_bib186","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12282-016-0734-z","article-title":"Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications","volume":"24","author":"Yang","year":"2017","journal-title":"Breast Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib187","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"issue":"7456","key":"10.1016\/j.semcancer.2025.12.006_bib188","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome [published correction appears in Nature. 2014 Feb 20;506(7488):396. Hattori, Masahisa [corrected to Hattori, Masahira]]","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib189","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.23845","article-title":"Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents","volume":"52","author":"Yu","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40168-018-0451-2","article-title":"Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers","volume":"6","author":"Dai","year":"2018","journal-title":"Microbiome"},{"issue":"8","key":"10.1016\/j.semcancer.2025.12.006_bib191","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1158\/1940-6207.CAPR-15-0090","article-title":"Bacterial prostatitis enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at multiple sites","volume":"8","author":"Sfanos","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.006_bib192","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrurol.2017.167","article-title":"The inflammatory microenvironment and microbiome in prostate cancer development","volume":"15","author":"Sfanos","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib193","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc3610","article-title":"The microbiome and cancer","volume":"13","author":"Schwabe","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.semcancer.2025.12.006_bib194","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","article-title":"Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects","volume":"45","author":"Daill\u00e8re","year":"2016","journal-title":"Immunity"},{"issue":"7318","key":"10.1016\/j.semcancer.2025.12.006_bib195","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.semcancer.2025.12.006_bib196","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1517\/17425255.2013.807798","article-title":"The effect of gut microbiota on drug metabolism","volume":"9","author":"Kang","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"11","key":"10.1016\/j.semcancer.2025.12.006_bib197","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/s41366-021-00866-7","article-title":"Spot-light on microbiota in obesity and cancer","volume":"45","author":"Marzullo","year":"2021","journal-title":"Int J. Obes. (Lond. )"},{"issue":"6264","key":"10.1016\/j.semcancer.2025.12.006_bib198","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.semcancer.2025.12.006_bib199","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/annonc\/mdz224","article-title":"Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab","volume":"30","author":"Chaput","year":"2019","journal-title":"Ann. Oncol."},{"issue":"6371","key":"10.1016\/j.semcancer.2025.12.006_bib200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25001762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25001762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:26:53Z","timestamp":1767716813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X25001762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":200,"alternative-id":["S1044579X25001762"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.12.006","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity and GEP-NEN: what\u2019s new?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}